Skip to main content

Find Clinical Trials

Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,765 public trials 829 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults

NCT05736835

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Velocity Clinical Research San Diego, California, United States

Velocity Clinical Research Boise, Idaho, United States

Velocity Clinical Research Sioux City, Iowa, United States

Velocity Clinical Research Rockville, Maryland, United States

View Trial Details

Completed

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

NCT05968989

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Secondary Databased Post-marketing Surveillance Study of BNT162b2

NCT06743334

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Pfizer Seoul, South Korea

View Trial Details

Completed

WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)

NCT04373551

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study

NCT06176859

Conditions: ART, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +16 more
Locations: Human Sciences Research Council Durban, KwaZulu-Natal, South Africa

View Trial Details

Completed

Start the Conversation: Evaluating Implementation of a Multi-level PrEP Initiative for Black Cisgender Women in Nola

NCT05909176

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Louisiana State University Health Sciences Center New Orleans, Louisiana, United States

View Trial Details

Completed

Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault

NCT06139354

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: District of Columbia Forensic Nurse Examiners Washington D.C., District of Columbia, United States

View Trial Details

Completed

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

NCT06742281

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Pinnacle Research Group, LLC Anniston, Alabama, United States

Velocity Clinical Research, Phoenix Phoenix, Arizona, United States

Velocity Clinical Research, Chula Vista Chula Vista, California, United States

Velocity Clinical Research, San Diego La Mesa, California, United States

View all 55 locations

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

NCT06698549

Conditions: COVID 19, COVID-19, Coronaviridae Infections, +10 more
Locations: University of Miami Miami, Florida, United States

Orlando Clinical Research Center Orlando, Florida, United States

Genesis Clinical Trials Tampa, Florida, United States

View Trial Details

Completed

A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

NCT05911360

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Bakersfield, California, United States

GSK Investigational Site Palm Springs, California, United States

GSK Investigational Site Washington D.C., District of Columbia, United States

View all 56 locations

View Trial Details